Skip to main content
. 2021 Oct 14;49(1):647–656. doi: 10.1007/s11033-021-06819-7

Table 1.

Summary of similarities and differences in published nanobodies

Nanobody Method Neutralizing pseudovirus (IC50) Affinity to RBD Function References
VHH-E Immunized phage display library 60 nM 1.86 nM Blocking RBD-ACE2 interaction/prevent the emergence of viral escape mutants [90]
Nb11-59 Immunized phage display library 36.7 nM 21 nM Blocking RBD-ACE2 interaction/high binding activity to the RBD [34]
Sybody (n3021) Ribosome and phage display 0.63 nM Blocking RBD-ACE2 interaction/binding to the full-length SARS-CoV-2 spike protein [91]
Sybody (MR3) Ribosome and phage display 40 nM 24.22 nM Blocking RBD-ACE2 interaction [92]
Nb6 yeast surface-displayed library 2 uM 210 nM Blocking RBD-ACE2 interaction/Binding Spike in a fully inactive conformation with its receptor binding domains [93]
H11-D4 naive llama single-domain antibody library 39 nM Blocking RBD-ACE2 interaction/Binding to all three RBDs in the spike trimer [94]
H11-H4 naive llama single-domain antibody library 12 nM Blocking RBD-ACE2 interaction/Binding to all three RBDs in the spike trimer [94]
Ty1 Immunized phage display library 54 nM 5–10 nM Blocking RBD-ACE2 interaction/Binding to the RBD with high affinity [95]
Nbs 89 Immune library and MS proteomic 0.133 nM 108 pM Blocking RBD-ACE2 interaction/inhibit viral infection [96]
WNb Immunized phage display library  ≤ 80 nM Blocking RBD-ACE2 interaction/neutralize both wildtype SARS-CoV-2 and the N501Y D614G variant [4]